Tobramycin
potency: ≥900μG/mg,98%
- Product Code: 96381
Alias:
Tobramycin; Tobramycin, Tobramycin Sulfate, Tobramycin, Tobramycin Base, O-3-amino-3-deoxy-alpha-O-glucopyranosyl-(1→ 6)-O-[2,6-Diamino-2,3,6-trideoxy-alpha-D-nuclear-hexapyranosyl-(1→4)]-2-deoxy-D-streptamethamine
CAS:
32986-56-4
Molecular Weight: | 467.51 g./mol | Molecular Formula: | C₁₈H₃₇N₅O₉ |
---|---|---|---|
EC Number: | 251-322-5 | MDL Number: | MFCD00077885 |
Melting Point: | 178 °C | Boiling Point: | |
Density: | Storage Condition: | 2~8°C |
Product Description:
Tobramycin is widely used in the treatment of bacterial infections, particularly those caused by Gram-negative bacteria. It is commonly administered as an injectable solution for severe infections such as sepsis, pneumonia, and infections of the urinary tract, abdomen, and skin. In ophthalmology, it is formulated as eye drops or ointments to treat bacterial conjunctivitis and other eye infections.
In cystic fibrosis patients, tobramycin is often used in inhaled form to manage chronic Pseudomonas aeruginosa infections in the lungs, helping to reduce bacterial load and improve respiratory function. Its effectiveness against resistant strains of bacteria makes it a critical component in combating hospital-acquired infections. Additionally, it is sometimes used in combination with other antibiotics to enhance its antibacterial spectrum and efficacy.
Product Specification:
Test | Specification |
---|---|
RESIDUE ON IGNITION | 0 1% |
HEAVY METALS | 0 0.003% |
PH10 IN WATER | 9-11 |
WATER BY KARL FISCHER | 0 8% |
APPEARANCE | WHITE TO OFF-WHITE HYGROSCOPIC POWDER |
POTENCY | 900ugmg |
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
0.250 | 10-20 days | Ft4,201.90 |
+
-
|
1.000 | 10-20 days | Ft10,558.63 |
+
-
|
5.000 | 10-20 days | Ft25,857.86 |
+
-
|
25.000 | 10-20 days | Ft76,065.20 |
+
-
|
100.000 | 10-20 days | Ft262,888.24 |
+
-
|
Tobramycin
Tobramycin is widely used in the treatment of bacterial infections, particularly those caused by Gram-negative bacteria. It is commonly administered as an injectable solution for severe infections such as sepsis, pneumonia, and infections of the urinary tract, abdomen, and skin. In ophthalmology, it is formulated as eye drops or ointments to treat bacterial conjunctivitis and other eye infections.
In cystic fibrosis patients, tobramycin is often used in inhaled form to manage chronic Pseudomonas aeruginosa infections in the lungs, helping to reduce bacterial load and improve respiratory function. Its effectiveness against resistant strains of bacteria makes it a critical component in combating hospital-acquired infections. Additionally, it is sometimes used in combination with other antibiotics to enhance its antibacterial spectrum and efficacy.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :